Aptevo Therapeutics Inc. (APVO) Social Stream



Aptevo Therapeutics Inc. (APVO): $4.69

0.63 (+15.52%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add APVO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#116 of 383

in industry

APTEVO THERAPEUTICS INC (APVO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering APTEVO THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 2 $69 $50 $59.5 $0.177 33515.82%
2022-05-12 2 $69 $36 $52.5 $0.177 29561.02%
2022-05-13 2 $36 $20 $28 $0.177 15719.21%
2023-02-13 1 $23 $13 $18 $0.177 10069.49%
2023-02-21 2 $23 $13 $18 $0.177 10069.49%
2023-04-24 2 $18 $13 $15.5 $0.177 8657.06%
2023-07-19 2 $18 $11 $14.5 $0.177 8092.09%
2023-08-10 1 $12 $12 $12 $0.177 6679.66%
2023-11-14 1 $10 $10 $10 $0.177 5549.72%

The Trend in the Analyst Price Target


APVO's average price target has moved down $20.5 over the prior 43 months.

APVO reports an average of 1,606.68% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-13 2 23 13 18.0 2.030 786.7%
2023-04-28 2 18 11 14.5 1.920 655.21%
2023-07-19 2 18 18 18.0 0.884 1936.2%
2023-07-19 2 18 11 14.5 0.884 1540.27%
2023-07-19 1 18 11 14.5 0.884 1540.27%

APVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


APVO's average broker recommendation rating improved by 0 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • APTEVO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 998.75% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, APTEVO THERAPEUTICS INC's number of analysts covering the stock is greater than 16.98% of them.
  • In terms of how APTEVO THERAPEUTICS INC fares relative to stocks in the micro market cap category, note that its variance in analysts' estimates is lower than -370.24% of that group.
  • APVO has a higher average analyst price target than 726.88% of stocks in the micro market cap category.

Stocks similar to APTEVO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PPBT, QLGN, and VTVT.

Is APVO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!